Thioridazine inhibits self-renewal in breast cancer cells via DRD2-dependent STAT3 inhibition, but induces a G1 arrest independent of DRD2
Matthew Tegowski(Duke University), Albert S. Baldwin(University of North Carolina at Chapel Hill), Cheng Fan(University of North Carolina at Chapel Hill)
Cited by 63
Related Papers
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
Evaluating the comparability of gene expression in blood and brain
|American Journal of Medical Genetics Part B Neuropsychiatric Genetics|2006|616